M&A Deal Summary

Stryker Acquires K2M

On August 30, 2018, Stryker acquired medical products company K2M from Welsh Carson Anderson & Stowe and Ferrer Freeman for 1.4B USD

Acquisition Highlights
  • This is Stryker’s 24th transaction in the Medical Products sector.
  • This is Stryker’s 5th largest (disclosed) transaction.
  • This is Stryker’s 23rd transaction in the United States.
  • This is Stryker’s 1st transaction in Virginia.

M&A Deal Summary

Date 2018-08-30
Target K2M
Sector Medical Products
Buyer(s) Stryker
Sellers(s) Welsh Carson Anderson & Stowe
Ferrer Freeman
Deal Type Add-on Acquisition
Deal Value 1.4B USD

Target

K2M

Leesburg, Virginia, United States
K2M is a spinal device company committed to the research, development, and commercialization of simplified solutions for the treatment of complex spinal pathologies and minimally invasive procedures. K2M is based in Leesburg, Virginia.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Stryker

Kalamazoo, Michigan, United States

Category Company
Founded 1941
Sector Medical Products
Employees52,000
Revenue 20.5B USD (2023)
DESCRIPTION
Stryker's corporate headquarters in Kalamazoo, Michigan.
Stryker's corporate headquarters in Kalamazoo, Michigan.

Stryker is a medical technology company. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. Stryker was founded in 1941 and is based in Kalamazoo, Michigan.


DEAL STATS #
Overall 34 of 48
Sector (Medical Products) 24 of 35
Type (Add-on Acquisition) 28 of 42
State (Virginia) 1 of 1
Country (United States) 23 of 33
Year (2018) 2 of 3
Size (of disclosed) 5 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-25 SafeAir AG

Root Längenbold, Switzerland

SafeAir AG is a Swiss medical device company dedicated to the design, development and manufacture of innovative surgical smoke evacuation solutions. The company's smoke evacuation products help reduce staff and patient exposure to hazards associated with surgical smoke.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-03 HyperBranch Medical Technology

Durham, North Carolina, United States

HyperBranch develops medical devices based on its proprietary polymers and cross-linked hydrogels. Its Adherus AutoSpray Dural Sealant product is one of only two FDA-approved dural sealants on the market.

Buy $220M

Seller(S) 2

SELLER

Welsh Carson Anderson & Stowe

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1979
PE ASSETS 31.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Welsh Carson Anderson & Stowe (WCAS) is a mega-sized, specialist private equity firm focused on investments in growth-oriented companies operating within the healthcare and technology/tech-enabled services industries. WCAS will consider small and large transactions; including venture investments, growth equity investments, buy-and-build transactions, public-to-private acquisitions, and corporate carve-outs. The Firm prefers control situations and generally seeks opportunities in the US. Welsh Carson Anderson & Stowe was formed in 1979 and is based in New York City.


DEAL STATS #
Overall 62 of 75
Sector (Medical Products) 5 of 6
Type (Add-on Acquisition) 39 of 44
State (Virginia) 2 of 2
Country (United States) 60 of 72
Year (2018) 3 of 3
Size (of disclosed) 8 of 33
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-17 Abzena

Cambridge, United Kingdom

Abzena is a life science company, that provides proprietary technologies and value-added services to enable the development of better biopharmaceuticals. Abzena comprises two wholly owned subsidiary businesses – PolyTherics and Antitope. Abzena is based in Cambridge, United Kingdom.

Buy £34M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-03 Green Street

Newport Beach, California, United States

Green Street is an independent research, analytics, trading, and consulting firm to the commercial real estate market in North American and Europe. Green Street was founded in 1985 and is based in Newport Beach, California.

Buy -
SELLER

Ferrer Freeman

Greenwich, Connecticut, United States

Category Private Equity Firm
Founded 1995
PE ASSETS 900M USD
Size Middle-Market
Type Sector Focused
DESCRIPTION

Ferrer Freeman & Co. (FFC) is a private equity firm that invests exclusively in healthcare companies generating sales minimum $20 to $200 million. FFC also invests in clinical products and outsourcing/infrastructure businesses serving the healthcare sector. FFC looks to commit $10 to $40 million per transaction and focuses primarily on growth capital financings and build-ups. However, the Firm will also selectively fund buyouts as well. Ferrer Freeman & Co. LLC was formed in 1995 and is based in Greenwich, Connecticut.


DEAL STATS #
Overall 23 of 24
Sector (Medical Products) 4 of 4
Type (Add-on Acquisition) 15 of 15
State (Virginia) 1 of 1
Country (United States) 23 of 24
Year (2018) 1 of 1
Size (of disclosed) 3 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-30 Drive DeVilbiss Healthcare

Port Washington, New York, United States

Drive DeVilbiss Healthcare manufactures a complete line of medical products, including mobility products, sleep and respiratory products, beds, bariatric products, wheelchairs, sleep surfaces and pressure prevention products, self-assist products, power operated wheelchairs, rehabilitation products, patient room equipment, personal care products and electrotherapy devices. Drive DeVilbiss Healthcare was founded in 2000 and is based in Port Washington, New York.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-21 Aerocare

Orlando, Florida, United States

Aerocare is a provider of oxygen, respiratory, sleep, and other chronic therapy services to patients in the home. AeroCare's patients typically suffer from the chronic obstructive pulmonary disease (COPD), obstructive sleep apnea (OSA), or congestive heart failure (CHF) and require in-home therapy services. Aerocare Holdings, Inc. was founded in 2000 and is based in Orlando, Florida.

Sell -